Correlation Between Burzynski Research and ProKidney Corp
Can any of the company-specific risk be diversified away by investing in both Burzynski Research and ProKidney Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Burzynski Research and ProKidney Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Burzynski Research and ProKidney Corp, you can compare the effects of market volatilities on Burzynski Research and ProKidney Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Burzynski Research with a short position of ProKidney Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Burzynski Research and ProKidney Corp.
Diversification Opportunities for Burzynski Research and ProKidney Corp
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Burzynski and ProKidney is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Burzynski Research and ProKidney Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProKidney Corp and Burzynski Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Burzynski Research are associated (or correlated) with ProKidney Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProKidney Corp has no effect on the direction of Burzynski Research i.e., Burzynski Research and ProKidney Corp go up and down completely randomly.
Pair Corralation between Burzynski Research and ProKidney Corp
Given the investment horizon of 90 days Burzynski Research is expected to generate 2.16 times more return on investment than ProKidney Corp. However, Burzynski Research is 2.16 times more volatile than ProKidney Corp. It trades about 0.05 of its potential returns per unit of risk. ProKidney Corp is currently generating about -0.01 per unit of risk. If you would invest 4.30 in Burzynski Research on September 1, 2024 and sell it today you would lose (0.80) from holding Burzynski Research or give up 18.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.21% |
| Values | Daily Returns |
Burzynski Research vs. ProKidney Corp
Performance |
| Timeline |
| Burzynski Research |
| ProKidney Corp |
Burzynski Research and ProKidney Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Burzynski Research and ProKidney Corp
The main advantage of trading using opposite Burzynski Research and ProKidney Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Burzynski Research position performs unexpectedly, ProKidney Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProKidney Corp will offset losses from the drop in ProKidney Corp's long position.| Burzynski Research vs. ProKidney Corp | Burzynski Research vs. Orchestra BioMed Holdings | Burzynski Research vs. Lixte Biotechnology Holdings | Burzynski Research vs. Oncology Pharma |
| ProKidney Corp vs. Relay Therapeutics | ProKidney Corp vs. Stoke Therapeutics | ProKidney Corp vs. Pliant Therapeutics | ProKidney Corp vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |